merck - Search News

Merck, China and Gardasil

Hosted on MSN · 11h

Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook

Merck's full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.

Business Insider · 2h

Merck Stock Loses 9% on Vaccine Shipment Halt to China

Merck & Co. (MRK) stock lost over 9% yesterday on announcing a temporary shipment halt of its Gardasil vaccine to China. The pharmaceutical

The Associated Press - Busines… · 17h

Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.

Merck beats estimates on fourth-quarter on earnings

Seeking Alpha · 21h

Merck stock slides as 2025 earnings outlook misses estimates

Merck (MRK) shares drop 8% premarket as 2025 outlook falls short of Wall Street estimates, despite beating Q4 expectations with Keytruda sales.

Merck beats estimates on fourth-quarter on earnings—but stock slides pre-market on tepid 2025 guidance

Merck ( MRK) reported fourth quarter and full year earnings Tuesday, in line with Wall Street estimates. The bad news: Its stock was down more than 8% in pre-market trading, largely because of weaker than expected 2025 guidance.

MarketWatch on MSN · 20h

Merck’s soft guidance offsets better-than-expected fourth-quarter earnings

Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings. Rahway, N.J.-based Merck had per-share income of $1.

12h

Merck touts 20 new ‘blockbuster’ drugs in development with $50 billion potential

Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.

13hon MSN

Why Merck Stock Is Plummeting Today

Merck's stock sank after the company reported fourth-quarter and year-end 2024 earnings this morning. Although it narrowly ...

17hon MSN

Merck Shares Hit After Guidance Falls Short, Gardasil Challenge

The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...

FiercePharma16h

Merck halts Gardasil shipments to China, withdraws $11B sales target as demand nosedives

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is ...

14h

Big Pharma, Bigger Bargain: Why Merck Stock Is Too Cheap To Ignore (Upgrade)

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

20h

Merck Posts Quarterly Profit on Sales Growth

The drug company’s outlook for 2025 and a slide in sales of its HPV vaccine, Gardasil, hit shares.

Merck’s earnings miss focused attention on Gardasil. The real issue is Keytruda

Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...

11hon MSN

These Stocks Are Moving the Most Today: Palantir, Alphabet, Tesla, Merck, PayPal, Super Micro, Spotify, Estée Lauder, and More

Palantir stock surges as artificial-intelligence gains drive an earnings and revenue beat, China begins an antitrust probe ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results